Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in J Neurol Retrieve available abstracts of 102 articles: HTML format Text format

Single Articles

January 2012
1. FERNANDEZ O , Oreja-Guevara C, Arroyo R, Izquierdo G, et al
   Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study.
   J Neurol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. BERNO S , Coenen M, Leib A, Cieza A, et al
   Validation of the Comprehensive International Classification of Functioning, Disability, and Health Core Set for multiple sclerosis from the perspective of physicians.
   J Neurol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. TURAKA K , Bryan JS
   Does fingolimod in multiple sclerosis patients cause macular edema?
   J Neurol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. FANCHAMPS MH , Gensicke H, Kuhle J, Kappos L, et al
   Screening for balance disorders in mildly affected multiple sclerosis patients.
   J Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PATRUCCO L , Rojas JI, Cristiano E
   Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes.
   J Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. MELIN A , Outteryck O, Collongues N, Zephir H, et al
   Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis.
   J Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. JACOBS JV , Kasser SL
   Effects of dual tasking on the postural performance of people with and without multiple sclerosis: a pilot study.
   J Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. STRUPP M
   Multiple sclerosis: iron mapping, predicting response to interferon-beta and effects of oral teriflunomide.
   J Neurol. 2011;258:2302-4.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
9. LIANG AL , Vavasour IM, Madler B, Traboulsee AL, et al
   Short-term stability of T (1) and T (2) relaxation measures in multiple sclerosis normal appearing white matter.
   J Neurol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. HO JK , Sadiq SA
    Use of intrathecal clonidine in patients with multiple sclerosis or spastic paraparesis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
11. D'HOOGHE MB , Haentjens P, Nagels G, D'Hooghe T, et al
    Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MAGRANER MJ , Coret F, Navarre A, Bosca I, et al
    Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study.
    J Neurol. 2011;258:1805-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
13. BLADH S , Nilsson MH, Hariz GM, Westergren A, et al
    Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. MCLEOD JG , Hammond SR, Kurtzke JF
    Migration and multiple sclerosis in United Kingdom and Ireland immigrants to Australia: a reassessment. II. Characteristics of early (pre-1947) compared to later migrants.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ECKSTEIN C , Saidha S, Levy M
    A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. HAYTON T , Furby J, Smith KJ, Altmann DR, et al
    Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. O'CONNOR K , Weinstock-Guttman B, Carl E, Kilanowski C, et al
    Patterns of dietary and herbal supplement use by multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
18. HAYTON T , Furby J, Smith KJ, Altmann DR, et al
    Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. NEUTEBOOM RF , Janssens AC, Siepman TA, Hoppenbrouwers IA, et al
    Pregnancy in multiple sclerosis: clinical and self-report scales.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
20. ZITTEL S , Bester M, Gerloff C, Munchau A, et al
    Symptomatic paroxysmal kinesigenic choreoathetosis as primary manifestation of multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
21. BATISTA S , Zivadinov R, Hoogs M, Bergsland N, et al
    Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
22. PALING D , Golay X, Wheeler-Kingshott C, Kapoor R, et al
    Energy failure in multiple sclerosis and its investigation using MR techniques.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. BUCK D , Hemmer B
    Treatment of multiple sclerosis: current concepts and future perspectives.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
24. SEPULVEDA M , Munteis E, Rubio MA, Pascual J, et al
    Adult onset Pompe disease associated with multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. YALDIZLI O , Glassl S, Sturm D, Papadopoulou A, et al
    Fatigue and progression of corpus callosum atrophy in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. FJELDSTAD AS , McDaniel J, Witman MA, Ives SJ, et al
    Vascular function and multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
27. DUDDY M , Haghikia A, Cocco E, Eggers C, et al
    Managing MS in a changing treatment landscape.
    J Neurol. 2011;258:728-39.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. TSCHAMPA HJ , Greschus S, Vinahl M, Urbach H, et al
    MS-like presentation of Alexander disease with multifocal lesions and oligoclonal bands.
    J Neurol. 2011;258:935-7.
    PubMed     Text format     Related articles   
    
    
    
    
29. JARIUS S , Wandinger KP, Platzer S, Wildemann B, et al
    Homology between Klebsiella pneumoniae and human aquaporin-4: no evidence for cross-reactivity in neuromyelitis optica. A study on 114 patients.
    J Neurol. 2011;258:929-31.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
30. STRUPP M
    Multiple sclerosis II: new diagnostic criteria, association with smoking and effects of cannabis on cognitive function.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
31. NOCITI V , Batocchi AP, Luigetti M, Conte A, et al
    Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
32. INVERNIZZI P , Bertolasi L, Bianchi MR, Turatti M, et al
    Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. HEALY B , Chitnis T, Engler D
    Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. MORROW SA , Jurgensen S, Forrestal F, Munchauer FE, et al
    Erratum to: Effects of acute relapses on neuropsychological status in multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
35. MCNAMARA PH , Costelloe L, Langan Y, Redmond J, et al
    Aquaporin-4 seropositivity in a patient with coeliac disease but normal neurological examination and imaging.
    J Neurol. 2011;258:702-3.
    PubMed     Text format     Related articles   
    
    
    
    
36. NAKAYAMA-ICHIYAMA S , Yokote T, Hiraoka N, Iwaki K, et al
    Multiple organ injury associated with neuromyelitis optica spectrum disorder in a low-grade B-cell lymphoma suspected of being follicular lymphoma.
    J Neurol. 2011;258:691-3.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
37. REIS A , Mateus C, Macario MC, de Abreu JR, et al
    Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. JOZEFOWICZ-KORCZYNSKA M , Pajor AM
    Evaluation of the smooth pursuit tests in multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. PROCHNOW D , Donell J, Schafer R, Jorgens S, et al
    Alexithymia and impaired facial affect recognition in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. FAREZ MF , Correale J
    Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. STRUPP M
    Multiple sclerosis: sun exposure and vitamin D, ultra-high-field imaging, and B cell clones in the meninges.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
42. HAVLA J , Gerdes LA, Meinl I, Krumbholz M, et al
    De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. SIMON KC , Munger KL, Kraft P, Hunter DJ, et al
    Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KOUTSIS G , Karadima G, Floroskufi P, Sfagos C, et al
    The rs10492972 KIF1B polymorphism and disease progression in Greek patients with multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
45. EDWARDS LJ , Sharrack B, Ismail A, Tumani H, et al
    Central inflammation versus peripheral regulation in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. MORROW SA , Jurgensen S, Forrestal F, Munchauer FE, et al
    Effects of acute relapses on neuropsychological status in multiple sclerosis patients.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. COENEN M , Cieza A, Freeman J, Khan F, et al
    The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. AKMAN-DEMIR G , Tuzun E, Waters P, Icoz S, et al
    Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
    J Neurol. 2011;258:464-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
49. MENGE T , Hartung HP, Kieseier BC
    Neutralizing antibodies in interferon beta treated patients with multiple sclerosis: knowing what to do now : Commentary to: 10.1007/s00415-010-5844-5 "One-year evaluation of factors affecting the biological activity of interferon beta in multiple scl
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
50. MCNICHOLAS N , Chataway J
    Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
51. LEBRUN C , Vermersch P, Brassat D, Defer G, et al
    Cancer and multiple sclerosis in the era of disease-modifying treatments.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. WIPFLER P , Pilz G, Broussalis E, Golaszewski SM, et al
    Acute pulmonary edema caused by a multiple sclerosis relapse.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
53. MORI F , Ljoka C, Magni E, Codeca C, et al
    Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
54. MCLEOD JG , Hammond SR, Kurtzke JF
    Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. VALENTINO P , Nistico R, Pirritano D, Bilotti G, et al
    Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report.
    J Neurol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
56. JUDICA E , Martinelli Boneschi F, Ungaro D, Comola M, et al
    Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. ARGYRIOU AA , Iconomou G, Ifanti AA, Karanasios P, et al
    Religiosity and its relation to quality of life in primary caregivers of patients with multiple sclerosis: a case study in Greece.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. AXELSSON M , Malmestrom C, Nilsson S, Haghighi S, et al
    Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.
    J Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
59. MALUCCHI S , Gilli F, Caldano M, Sala A, et al
    One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. ZAARAOUI W , Reuter F, Rico A, Faivre A, et al
    Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
61. STRUPP M
    News on multiple sclerosis: induction of immune tolerance, a biomarker for predicting disease activity, and CSF ferritin levels.
    J Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
62. SACCO R , Bussman R, Oesch P, Kesselring J, et al
    Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. DISANTO G , Ramagopalan SV, Para AE, Handunnetthi L, et al
    The emerging role of vitamin D binding protein in multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. ANDERSON G , Meyer D, Herrman CE, Sheppard C, et al
    Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study.
    J Neurol. 2010;257:1917-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. PETEREIT HF , Reske D, Tumani H, Jarius S, et al
    Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis.
    J Neurol. 2010;257:1855-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
66. MACMANUS DG , Miller DH, Kappos L, Gold R, et al
    BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. MUNGER KL , Chitnis T, Frazier AL, Giovannucci E, et al
    Dietary intake of vitamin D during adolescence and risk of multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. AKBAR N , Honarmand K, Kou N, Feinstein A, et al
    Validity of a computerized version of the Symbol Digit Modalities Test in multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. ZWIBEL H , Pardo G, Smith S, Denney D, et al
    A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. SENA A , Bendtzen K, Cascais MJ, Pedrosa R, et al
    Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta.
    J Neurol. 2010;257:1703-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. SELLNER J , Schirmer L, Hemmer B, Muhlau M, et al
    The radiologically isolated syndrome: take action when the unexpected is uncovered?
    J Neurol. 2010;257:1602-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. FLACHENECKER P , Khil L, Bergmann S, Kowalewski M, et al
    Development and pilot phase of a European MS register.
    J Neurol. 2010;257:1620-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
73. HELLWIG K , Gold R
    Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
74. MORGANTE F , Dattola V, Crupi D, Russo M, et al
    Is central fatigue in multiple sclerosis a disorder of movement preparation?
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. LI Y , Zeng C, Luo T
    Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. HONARMAND K , Akbar N, Kou N, Feinstein A, et al
    Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
77. DI FILIPPO M , Luchetti E, Prontera P, Donti E, et al
    Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
78. HANE A , Bargetzi M, Hewer E, Bruehlmeier M, et al
    Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour.
    J Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
79. HOROWSKI S , Zettl UK, Benecke R, Walter U, et al
    Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. MERKELBACH S , Schulz H, Kolmel HW, Gora G, et al
    Fatigue, sleepiness, and physical activity in patients with multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. NESSLER S , Bruck W
    Advances in multiple sclerosis research in 2009.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. MARCEL C , Anheim M, Flamand-Rouviere C, Heran F, et al
    Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases.
    J Neurol. 2010;257:1369-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
83. SADIQ SA , Simon EV, Puccio LM
    Intrathecal methotrexate treatment in multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. ALVARENGA MP , Thuler LC, Neto SP, Vasconcelos CC, et al
    The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro.
    J Neurol. 2010;257:992-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. PENG F , Zhong X, Deng X, Qiu W, et al
    Serum uric acid levels and neuromyelitis optica.
    J Neurol. 2010;257:1021-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. FLET L , Polard E, Guillard O, Leray E, et al
    3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.
    J Neurol. 2010;257:937-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. KIM SH , Kim SM, Vincent A, Ahn SW, et al
    Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis.
    J Neurol. 2010;257:920-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
88. SIEPMAN TA , Wefers Bettink-Remeijer M, Hintzen RQ
    Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. FURBY J , Hayton T, Altmann D, Brenner R, et al
    A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. SASTRE-GARRIGA J , Tintore M, Nos C, Tur C, et al
    Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS.
    J Neurol. 2010;257:742-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
91. STRUPP M
    Epstein-Barr virus, 9.4 T MRI and phosphodiesterase inhibitors in multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
92. FERNANDEZ O , Fernandez V, Arbizu T, Izquierdo G, et al
    Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study).
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. ROJAS JI , Patrucco L, Cristiano E
    Erratum to: Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
94. GUIMOND C , Dyment DA, Ramagopalan SV, Giovannoni G, et al
    Prevalence of MS in Iranian immigrants to British Columbia, Canada.
    J Neurol. 2010;257:667-8.
    PubMed     Text format     Related articles   
    
    
    
    March 2010
95. OGUZ KK , Kurne A, Aksu AO, Taskiran A, et al
    A comparative assessment of cerebral white matter by magnetization transfer imaging in early- and adult-onset multiple sclerosis patients matched for disease duration.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. YALDIZLI O , Atefy R, Gass A, Sturm D, et al
    Corpus callosum index and long-term disability in multiple sclerosis patients.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
97. STRUPP M
    Multiple sclerosis: transformation, freedom and clarity for our patients?
    J Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
98. IGNACIO RJ , Liliana P, Edgardo C
    Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. STEFFENSEN LH , Mellgren SI, Kampman MT
    Erratum to: Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
100. HENDERSON AP , Trip SA, Schlottmann PG, Altmann DR, et al
     A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis.
     J Neurol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. OUTTERYCK O , Ongagna JC, Zephir H, Fleury MC, et al
     Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice.
     J Neurol. 2010;257:207-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
102. SIMMONS RD , Tribe KL, McDonald EA
     Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management.
     J Neurol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: